Header Logo

Connection

Mark Pollack to Drug Therapy, Combination

This is a "connection" page, showing publications Mark Pollack has written about Drug Therapy, Combination.
Connection Strength

1.064
  1. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53.
    View in: PubMed
    Score: 0.110
  2. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
    View in: PubMed
    Score: 0.096
  3. Refractory generalized anxiety disorder. J Clin Psychiatry. 2009; 70 Suppl 2:32-8.
    View in: PubMed
    Score: 0.078
  4. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62.
    View in: PubMed
    Score: 0.074
  5. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.
    View in: PubMed
    Score: 0.073
  6. Novel treatment approaches for refractory anxiety disorders. Depress Anxiety. 2008; 25(6):467-76.
    View in: PubMed
    Score: 0.073
  7. An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
    View in: PubMed
    Score: 0.064
  8. Comorbid anxiety and depression. J Clin Psychiatry. 2005; 66 Suppl 8:22-9.
    View in: PubMed
    Score: 0.059
  9. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res. 2004 Sep-Oct; 38(5):491-5.
    View in: PubMed
    Score: 0.058
  10. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82.
    View in: PubMed
    Score: 0.054
  11. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002 May; 69(1-3):201-8.
    View in: PubMed
    Score: 0.049
  12. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3.
    View in: PubMed
    Score: 0.038
  13. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5.
    View in: PubMed
    Score: 0.036
  14. Treatment of dysphoric mania with nefazodone. Am J Psychiatry. 1996 May; 153(5):732-3.
    View in: PubMed
    Score: 0.032
  15. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5.
    View in: PubMed
    Score: 0.028
  16. Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry. 1993 Nov; 38 Suppl 4:S122-6.
    View in: PubMed
    Score: 0.027
  17. Adjunctive yohimbine for treatment in refractory depression. Biol Psychiatry. 1993 Feb 01; 33(3):220-1.
    View in: PubMed
    Score: 0.026
  18. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
    View in: PubMed
    Score: 0.019
  19. Verapamil in the treatment of recurrent unipolar depression. Biol Psychiatry. 1987 Jun; 22(6):779-82.
    View in: PubMed
    Score: 0.017
  20. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
    View in: PubMed
    Score: 0.014
  21. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9.
    View in: PubMed
    Score: 0.012
  22. Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines. J Clin Psychopharmacol. 2001 Feb; 21(1):104-7.
    View in: PubMed
    Score: 0.011
  23. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
    View in: PubMed
    Score: 0.010
  24. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.